Evidence map›Paper›PMID 30473680›Full record

ArticleFrontiers in microbiology2018

Kiyoshi F Fukutani, Cristiana M Nascimento-Carvalho, Maiara L Bouzas, Juliana R Oliveira, Aldina Barral, Tim Dierckx, Ricardo Khouri, Helder I Nakaya, Bruno B Andrade, Johan Van Weyenbergh and 1 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kiyoshi F FukutaniInstituto Gonçalo Moniz-FIOCRUZ, Salvador, Brazil.
Cristiana M Nascimento-CarvalhoSchool of Medicine, Federal University of Bahia, Salvador, Brazil.
Maiara L BouzasSchool of Medicine, Federal University of Bahia, Salvador, Brazil.
Juliana R OliveiraSchool of Medicine, Federal University of Bahia, Salvador, Brazil.
Aldina BarralInstituto Gonçalo Moniz-FIOCRUZ, Salvador, Brazil.
Tim DierckxDepartment of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Ricardo KhouriInstituto Gonçalo Moniz-FIOCRUZ, Salvador, Brazil.
Helder I NakayaDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Bruno B AndradeInstituto Gonçalo Moniz-FIOCRUZ, Salvador, Brazil.
Johan Van WeyenberghDepartment of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Camila I de OliveiraInstituto Gonçalo Moniz-FIOCRUZ, Salvador, Brazil.

Funding

Inflammatory determinants of disease severity and treatment outcome in TB patientsU01AI115940 · NIAID · UNIVERSITY OF CAPE TOWN · PI SHER, ALAN, WILKINSON, ROBERT JOHN · 2015 to 2019
$1.1M
NIAID NIH HHS U01 AI115940
6 · The paper itself

Abstract

Acute respiratory infection (ARI) is the most frequent cause for hospitalization in infants and young children. Using multiplexed nCounter technology to digitally quantify 600 human mRNAs in parallel with 14 virus- and 5 bacterium-specific RNAs, we characterized viral and bacterial presence in nasopharyngeal aspirates (NPA) of 58 children with ARI and determined the corresponding

Indexed as

adaptive immunityARIimmune responseinnate immunityinterferonnCounternetwork analysisviral load

Identifiers

PMID30473680
PMCPMC6238668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.